Skip to main content
An official website of the United States government
Email

Current Showcase Companies

Each year, NCI SBIR conducts a private-sector peer review with more than 70 third-party investors and strategic partners to determine which companies in the NCI SBIR portfolio are ready to attract financing and/or partnerships. Below, we present the 30 companies selected for 2026. These companies will be attending and pitching at leading investor conferences through the summer of 2027.

If you are an investor or company interested in learning more about any of the companies, you can find their contact information below or contact Brittany Connors for more information or a direct introduction.

Biopharmaceuticals

Devices

  • Cordance Medical, Inc.

    Mountain View, CA
    Non-Invasive, Focused Ultrasound System to Precisely Open the Blood-Brain Barrier
    Bhaskar Ramamurthy | bhaskar.ram@cordancemedical.com

  • Gradient Medical, Inc.

    Raleigh, NC
    Next-Generation Cancer Ablation Platform
    Jordan Fong | jordan.fong@gradient-medical.com

  • iSono Health, Inc.

    Sunnyvale, CA
    AI-Powered, Hands-Free Wearable and Automated Breast Ultrasound Imaging System
    Neda Razavi | neda@isonohealth.com

  • Leuko Labs

    Leuko Labs, Inc.

    Cambridge, MA
    Non-Invasive White Blood Cell Monitoring Device
    Carlos Castro Gonzalez | carlos@leuko.com

  • Lumicell, Inc.

    Waltham, MA
    Real-Time Fluorescence-Guided Imaging for More Precise Cancer Surgery
    Jorge Ferrer | jmferrer@lumicell.com

  • Navigation Sciences, Inc.

    Brookline, MA
    GPS Navigation for Precise Margin Control During Surgical Resection
    Alan Lucas | alan.lucas@navigationsci.com

  • SafeGuard Surgical, Inc.

    Tampa, FL
    Biodegradable Intraluminal Barrier Device Platform to Prevent Anastomotic Leakage Following Cancer Resection Surgery
    Scott Kelley | drscottkelley@drscottkelley.com

  • Syntr Health Technologies, Inc.

    Irvine, CA
    Point-of-Care Technologies for Safer, More Effective, and More Accessible Tissue Reconstruction
    Ahmed | azobi@syntrtech.com

Diagnostics/Tools

  • Early is Good, Inc.

    Indianapolis, IN
    Multi-omics Liquid Biopsy Platform
    Thakshila Liyanage | thakshila@earlyisgood.com

  • Eximius Diagnostics Corporation

    Los Angeles
    Extracelleular Vesicle-based Liquid Biopsy Tests
    Matthew Smalley | msmalley@eximiusdx.com

  • ImCare Biotech, Inc.

    Doylestown, PA
    Blood-based Liver Cancer Diagnostic
    Aaron Yefel Lu | yl@imcarebiotech.com

  • Orbit Genomics, Inc.

    Boulder, CO
    Gemonic Cancer Diagnostics Platform
    Dede Willis | dwillis@orbitgenomics.com

  • Sus Clinicals, Inc.

    Cincinnati, OH
    Large-animal Preclinical Cancer Model
    Kyle Schachtschneider | kyle@susclinicals.com

Digital Health

Email